Status:
COMPLETED
PAP Therapy in Patients With Obesity Hypoventilation Syndrome
Lead Sponsor:
University of Crete
Conditions:
Obesity Hypoventilation Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The role of different levels of compliance and long-term effects of positive airway pressure (PAP) therapy on gas exchange, sleepiness, quality of life, depression and death rate in patients with obes...
Detailed Description
Various forms of positive airway pressure (PAP) therapy are effective in providing short and long-term benefits in these patients with or without obstructive sleep apnea (OSA). However, there are limi...
Eligibility Criteria
Inclusion
- aged between 18 and 80 years
- Obesity hypoventilation syndrome diagnosis (OHS)
- clinically stable for at least 4 weeks prior to the enrolmenT
- above-elementary school education.
Exclusion
- refusal to participate
- refusal of PAP therapy
- central sleep apnea syndromes
- restrictive ventilation syndromes
- severe congestive heart failure
- a history of life-threatening arrhythmias
- severe cardiomyopathy
- significant chronic kidney disease
- untreated hypothyroidism
- family or personal history of mental illness
- drug or alcohol abuse
- sedative use
- severe cognitive impairment
- concurrent oncological diseases
- history of narcolepsy or restless legs syndrome.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT03449641
Start Date
June 1 2009
End Date
June 1 2012
Last Update
March 1 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.